$VTR
Ventas, Inc. Stock $vtr

$vtr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000074026024000139 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.201B	$1.200B	$1.077B
YoY Change	8.55%	11.39%	5.87%
Cost Of Revenue	$681.8M	$689.3M	$609.6M
YoY Change	9.22%	13.06%	12.06%
Gross Profit	$519.2M	$510.7M	$467.6M
YoY Change	7.69%	9.21%	-1.25%
Gross Profit Margin	43.23%	42.56%	43.41%
Selling, General & Admin	$37.73M	$48.74M	$44.80M
YoY Change	9.67%	8.79%	4.19%
% of Gross Profit	7.27%	9.54%	9.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$339.8M	$300.3M	$282.1M
YoY Change	11.54%	6.43%	-2.4%
% of Gross Profit	65.46%	58.8%	60.33%
Operating Expenses	$332.7M	$349.0M	$318.3M
YoY Change	-1.89%	9.64%	0.17%
Operating Profit	$186.5M	$161.7M	$149.3M
YoY Change	30.41%	8.29%	-4.15%
Interest Expense	$149.3M	-$158.3M	$128.1M
YoY Change	-233.25%	-223.61%	15.6%
% of Operating Profit	80.03%	-97.92%	85.79%
Other Income/Expense, Net	-$8.128M	-$14.31M	-$7.762M
YoY Change	-127.07%	84.39%	-128.55%
Pretax Income	-$19.08M	-$15.54M	$11.53M
YoY Change	-120.03%	-234.79%	-69.59%
Income Tax	$7.766M	-$3.004M	-$2.802M
% Of Pretax Income			-24.3%
Net Earnings	$21.17M	-$14.31M	$18.91M
YoY Change	-79.54%	-175.68%	-53.41%
Net Earnings / Revenue	1.76%	-1.19%	1.76%
Basic Earnings Per Share	$0.05	-$0.04	$0.04
Diluted Earnings Per Share	$0.05	-$0.04	$0.04
COMMON SHARES
Basic Shares Outstanding	404.8M shares	402.5M shares	400.0M shares
Diluted Shares Outstanding	411.8M shares	407.2M shares	403.8M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$557.1M	$632.4M	$145.4M
YoY Change	301.8%	335.1%	-2.84%
Cash & Equivalents	$557.1M	$632.4M	$145.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$557.1M	$632.4M	$145.4M
YoY Change	301.8%	335.1%	-2.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.48B	$21.55B	$21.00B
YoY Change	-4.48%	2.63%	-4.47%
Goodwill	$1.045B	$1.045B	$1.045B
YoY Change	-0.01%	0.03%	-0.09%
Intangibles
YoY Change
Long-Term Investments	$686.7M	$601.4M	$699.6M
YoY Change	9.15%	-14.04%	14.05%
Other Assets	$234.0M	$99.05M	$81.05M
YoY Change	134.67%	22.21%	-7.09%
Total Long-Term Assets	$23.97B	$24.04B	$23.85B
YoY Change	-3.85%	0.8%	-3.84%
TOTAL ASSETS
Total Short-Term Assets	$557.1M	$632.4M	$145.4M
Total Long-Term Assets	$23.97B	$24.04B	$23.85B
Total Assets	$24.53B	$24.67B	$23.99B
YoY Change	-2.16%	2.83%	-3.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.003B	$1.020B	$1.007B
YoY Change	-6.22%	1.28%	-6.68%
Accrued Expenses	$335.2M	$325.4M	$283.5M
YoY Change	6.85%	14.78%	-2.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$190.2M	$1.167B
YoY Change
Total Short-Term Liabilities	$1.529B	$1.346B	$1.291B
YoY Change	10.49%	4.24%	-5.69%
LONG-TERM LIABILITIES
Long-Term Debt	$12.98B	$13.56B	$12.34B
YoY Change	-2.77%	9.83%	-0.57%
Other Long-Term Liabilities	$4.988M	$7.605M	$4.412M
YoY Change	68.57%	72.37%	-47.54%
Total Long-Term Liabilities	$12.99B	$13.56B	$12.35B
YoY Change	-2.75%	9.85%	-0.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.529B	$1.346B	$1.291B
Total Long-Term Liabilities	$12.99B	$13.56B	$12.35B
Total Liabilities	$14.55B	$14.98B	$13.67B
YoY Change	-1.89%	9.62%	-1.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.577B	-$6.410B	-$5.611B
YoY Change	15.63%	14.24%	16.37%
Common Stock	$16.24B	$15.86B	$15.66B
YoY Change	3.53%	1.25%	0.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares			275.0K shares
Shareholders Equity	$9.619B	$9.688B	$9.997B
YoY Change
Total Liabilities & Shareholders Equity	$24.53B	$24.67B	$23.99B
YoY Change	-2.16%	2.83%	-3.83%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$21.17M	-$14.31M	$18.91M
YoY Change	-79.54%	-175.68%	-53.41%
Depreciation, Depletion And Amortization	$339.8M	$300.3M	$282.1M
YoY Change	11.54%	6.43%	-2.4%
Cash From Operating Activities	$335.9M	$266.4M	$242.8M
YoY Change	7.71%	9.73%	-11.56%
INVESTING ACTIVITIES
Capital Expenditures	$152.6M	$134.1M	$112.7M
YoY Change	18.83%	19.06%	-251.58%
Acquisitions
YoY Change
Other Investing Activities	-$114.2M	-$10.46M	$56.38M
YoY Change	-299.99%	-118.56%	-115.53%
Cash From Investing Activities	-$266.8M	-$144.6M	-$56.28M
YoY Change	274.05%	156.91%	-87.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-140.3M	$4.824M	-$162.1M
YoY Change	-37.94%	-102.98%	-198.02%
NET CHANGE
Cash From Operating Activities	335.9M	$266.4M	$242.8M
Cash From Investing Activities	-266.8M	-$144.6M	-$56.28M
Cash From Financing Activities	-140.3M	$4.824M	-$162.1M
Net Change In Cash	-71.18M	$126.7M	$24.43M
YoY Change	-590.15%	418.56%	836.37%
FREE CASH FLOW
Cash From Operating Activities	$335.9M	$266.4M	$242.8M
Capital Expenditures	$152.6M	$134.1M	$112.7M
Free Cash Flow	$183.3M	$132.3M	$130.2M
YoY Change	-0.08%	1.66%	-62.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	404433000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	404433000	shares
	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P8Y1M6D
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	374245000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	352743000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1289000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13589000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6780000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1743000	usd
CY2024Q1	us-gaap	Revenues Revenues	1199914000	usd
CY2023Q1	us-gaap	Revenues Revenues	1077245000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	149933000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	128075000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300255000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	282119000	usd
CY2024Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	687497000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	607931000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48737000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44798000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-252000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4677000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1386000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-68000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-8064000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	15714000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	0	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1334000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7762000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	1207416000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	1065713000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7502000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11532000	usd
CY2024Q1	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-8383000	usd
CY2023Q1	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-5623000	usd
CY2024Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	341000	usd
CY2023Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	10201000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3004000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2802000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12540000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	18912000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1772000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1395000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14312000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17517000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	3935000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	3899000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	120000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	11022000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-8802000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	15077000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4903000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2537000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14009000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	646000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	161000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1891000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13848000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9544405000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	15077000	usd
CY2024Q1	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	7983000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	182018000	usd
CY2024Q1	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	82329000	usd
CY2024Q1	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	20359000	usd
CY2024Q1	vtr	Adjustments To Equity Redemption Of Limited Partnership Units AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits	-796000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9458833000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10221677000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4903000	usd
CY2023Q1	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	-134000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	179199000	usd
CY2023Q1	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	4973000	usd
CY2023Q1	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	3077000	usd
CY2023Q1	vtr	Adjustments To Equity Redemption Of Limited Partnership Units AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits	-69000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10064602000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	300255000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	282119000	usd
CY2024Q1	vtr	Amortization Of Deferred Revenue And Lease Intangibles AmortizationOfDeferredRevenueAndLeaseIntangibles	-13645000	usd
CY2023Q1	vtr	Amortization Of Deferred Revenue And Lease Intangibles AmortizationOfDeferredRevenueAndLeaseIntangibles	-14913000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	7298000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	4154000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-68000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-8064000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16284000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15060000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	2612000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	445000	usd
CY2024Q1	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-252000	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	usd
CY2024Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	341000	usd
CY2023Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	10201000	usd
CY2024Q1	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-4696000	usd
CY2023Q1	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-4299000	usd
CY2024Q1	vtr	Gain Loss From Equity Method Investments And Other Items Non Cash Portion GainLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion	-8383000	usd
CY2023Q1	vtr	Gain Loss From Equity Method Investments And Other Items Non Cash Portion GainLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion	-5623000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	4576000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5472000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5422000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1526000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	25839000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16885000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	6096000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-17006000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11533000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18236000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	266448000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	242817000	usd
CY2024Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	36092000	usd
CY2023Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	0	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	5232000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	289000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	40016000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	46417000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	268000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	44354000	usd
CY2024Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	84737000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	69079000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	49387000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	43577000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	11179000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	35792000	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1756000	usd
CY2023Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1686000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144587000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56280000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-5708000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	14340000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	22164000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	555489000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	343900000	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	419310000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	343876000	usd
CY2024Q1	vtr	Payments For Noncontrolling Interests PaymentsForNoncontrollingInterests	0	usd
CY2023Q1	vtr	Payments For Noncontrolling Interests PaymentsForNoncontrollingInterests	110000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5283000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4027000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	77430000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	182854000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	181422000	usd
CY2024Q1	vtr	Cash Distributions To Redeemable Op Unitholders CashDistributionsToRedeemableOPUnitholders	1555000	usd
CY2023Q1	vtr	Cash Distributions To Redeemable Op Unitholders CashDistributionsToRedeemableOPUnitholders	1539000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	1064000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	655000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3534000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2973000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4473000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2566000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1736000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-11382000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-13025000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4824000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-162107000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	126685000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	24430000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1738000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563462000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170745000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	688409000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	195281000	usd
CY2024Q1	us-gaap	Transfer Of Investments TransferOfInvestments	942000	usd
CY2023Q1	us-gaap	Transfer Of Investments TransferOfInvestments	0	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	83000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	0	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	632000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	usd
CY2024Q1	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	393000	usd
CY2023Q1	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	0	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1—DESCRIPTION OF BUSINESS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ventas, Inc., (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us,” “our,” “Company” and other similar terms) an S&P 500 company, is a real estate investment trust (“REIT”) focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. We hold a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. As of March 31, 2024, we owned or had investments in approximately 1,400 properties (including properties classified as held for sale and unconsolidated properties). Our company is headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code (the “Code”), commencing with our taxable year ended December 31, 1999. Provided we qualify for taxation as a REIT, we generally will not be required to pay U.S. federal corporate income taxes on our REIT taxable income that is currently distributed to our stockholders. In order to maintain our qualification as a REIT, we must satisfy a number of highly technical requirements, which impact how we invest in, operate or manage our assets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in our portfolio of real estate assets through wholly-owned subsidiaries and other co-investment entities. We operate through three reportable business segments: senior housing operating portfolio, which we also refer to as “SHOP,” outpatient medical and research portfolio, which we also refer to as “OM&R,” and triple-net leased properties. Non-segment assets consist primarily of corporate assets, including cash, restricted cash, loans receivable and investments and miscellaneous accounts receivable as well as investments in unconsolidated entities. In addition, from time to time, we make secured and unsecured loans and other investments relating to real estate or operators. Our chief operating decision maker evaluates performance of the combined properties in each operating segment and determines how to allocate resources to these segments, in significant part, based on net operating income (“NOI”) and related measures for each segment. See “Note 16 – Segment Information.” For a discussion of our definition of NOI and for a reconciliation of NOI to our net income attributable to common stockholders, as computed in accordance with U.S. generally accepted accounting principles (“GAAP”), see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures.”</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have investments in unconsolidated entities, including through our third-party institutional capital management business, Ventas Investment Management (“VIM”). Through VIM, we partner with third-party institutional investors to invest in real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner, including our open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the “Ventas Fund”).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information for our consolidated reportable business segments and non-segment assets for the three months ended March 31, 2024 (dollars in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.348%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total NOI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Total NOI</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Consolidated Properties</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior housing operating portfolio (SHOP)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,483 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outpatient medical and research portfolio (OM&R)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,570 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triple-net leased properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-segment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,884 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">______________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">“NOI” is defined as total revenues, less interest and other income, property-level operating expenses and third party capital management expenses. See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and a reconciliation of net income attributable to common stockholders, as computed in accordance with GAAP, to NOI.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NOI for non-segment includes management fees and promote revenues, net of expenses related to our third-party institutional capital management business, income from loans and investments and various corporate-level expenses not directly attributable to any of our three reportable business segments.</span></div>
CY2024Q1	vtr	Number Of Real Estate Properties Wholly Owned And Unconsolidated NumberOfRealEstatePropertiesWhollyOwnedAndUnconsolidated	1400	property
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	vtr	Net Operating Income NetOperatingIncome	503884000	usd
CY2024Q1	vtr	Net Operating Income Percent NetOperatingIncomePercent	1
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	1340	property
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q4	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	usd
CY2024Q1	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	244169000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2022Q1	vtr	Operating Lease Lease Income Lease Payments Annual Increase OperatingLeaseLeaseIncomeLeasePaymentsAnnualIncrease	0.03
CY2022Q1	vtr	Operating Lease Lease Income Lease Payments Full Years Base Rent OperatingLeaseLeaseIncomeLeasePaymentsFullYearsBaseRent	1.03
CY2022Q1	vtr	Operating Lease Lease Income Lease Payments Annual Increase OperatingLeaseLeaseIncomeLeasePaymentsAnnualIncrease	0.03
CY2024Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	41317000	usd
CY2024Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	7605000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	56489000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	9243000	usd
CY2024Q1	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	59200000	usd
CY2023Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	54100000	usd
CY2024Q1	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	63092000	usd
CY2024Q1	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	3908000	usd
CY2024Q1	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	59184000	usd
CY2024Q1	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	57545000	usd
CY2023Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	58114000	usd
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	3976000	usd
CY2023Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	54138000	usd
CY2023Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	53147000	usd
CY2024Q1	us-gaap	Real Estate Investments RealEstateInvestments	601406000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	598206000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1045048000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1045176000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1221231000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1189817000	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1298344000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y8M12D
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1337945000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y
CY2024Q1	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	306197000	usd
CY2024Q1	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P8Y
CY2023Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	306499000	usd
	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P8Y1M6D
CY2024Q1	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	usd
CY2023Q4	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	241600000	usd
CY2024Q1	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	usd
CY2023Q4	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	usd
CY2024Q1	vtr	Finite And Indefinite Lived Intangible Liabilities Net FiniteAndIndefiniteLivedIntangibleLiabilitiesNet	79094000	usd
CY2024Q1	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P8Y
CY2023Q4	vtr	Finite And Indefinite Lived Intangible Liabilities Net FiniteAndIndefiniteLivedIntangibleLiabilitiesNet	81965000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	196254000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	194108000	usd
CY2024Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	122982000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	118556000	usd
CY2024Q1	vtr	Investment In Unconsolidated Operating Entities InvestmentInUnconsolidatedOperatingEntities	74626000	usd
CY2023Q4	vtr	Investment In Unconsolidated Operating Entities InvestmentInUnconsolidatedOperatingEntities	80312000	usd
CY2024Q1	vtr	Non Mortgage Loans Receivable Net NonMortgageLoansReceivableNet	29365000	usd
CY2023Q4	vtr	Non Mortgage Loans Receivable Net NonMortgageLoansReceivableNet	26152000	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5365000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5584000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	216820000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	199417000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	714014000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	683410000	usd
CY2024Q1	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2023Q4	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13632013000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13568598000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	82534000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	84034000	usd
CY2024Q1	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	15917000	usd
CY2023Q4	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	17081000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10202000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10749000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13555194000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13490896000	usd
CY2024Q1	vtr	Commercial Paper Program Capacity CommercialPaperProgramCapacity	1000000000	usd
CY2024Q1	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	15000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1206488000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1862211000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1944547000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1601668000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1526273000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	5490826000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13632013000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13632013000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13568598000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2800000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	20200000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24500000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1800000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1800000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-50475000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-56596000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1136000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1256000	usd
CY2024Q1	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	32057000	usd
CY2023Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	22095000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19554000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35757000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12540000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	18912000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1772000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1395000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14312000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17517000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	403365000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	399989000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	416000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	320000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3446000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3483000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	407227000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	403792000	shares
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	vtr	Intersegment Sales And Transfers IntersegmentSalesAndTransfers	0	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	374245000	usd
CY2024Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1289000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6780000	usd
CY2024Q1	us-gaap	Revenues Revenues	1199914000	usd
CY2024Q1	us-gaap	Revenues Revenues	1199914000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6780000	usd
CY2024Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	687497000	usd
CY2024Q1	vtr	Net Operating Income NetOperatingIncome	503884000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6780000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	149933000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300255000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48737000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-252000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4677000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-68000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	15714000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1334000	usd
CY2024Q1	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-8383000	usd
CY2024Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	341000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3004000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12540000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-12540000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1772000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14312000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	352743000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13589000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1743000	usd
CY2023Q1	us-gaap	Revenues Revenues	1077245000	usd
CY2023Q1	us-gaap	Revenues Revenues	1077245000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1743000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	607931000	usd
CY2023Q1	vtr	Net Operating Income NetOperatingIncome	465865000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1743000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	128075000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	282119000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44798000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1386000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-8064000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7762000	usd
CY2023Q1	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-5623000	usd
CY2023Q1	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	10201000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2802000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	18912000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18912000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1395000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17517000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	170216000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	112656000	usd
CY2024Q1	us-gaap	Revenues Revenues	1199914000	usd
CY2023Q1	us-gaap	Revenues Revenues	1077245000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	21550806000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	21748950000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0000740260-24-000139-index-headers.html	Edgar Link	pending
0000740260-24-000139-index.html	Edgar Link	pending
0000740260-24-000139.txt	Edgar Link	pending
0000740260-24-000139-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vtr-20240331.htm	Edgar Link	pending
vtr-20240331.xsd	Edgar Link	pending
vtr-ex22_033124.htm	Edgar Link	pending
vtr-ex311_033124.htm	Edgar Link	pending
vtr-ex312_033124.htm	Edgar Link	pending
vtr-ex321_033124.htm	Edgar Link	pending
vtr-ex322_033124.htm	Edgar Link	pending
vtr-ex41_033124tenthsupp.htm	Edgar Link	pending
vtr-ex41_033124tenthsupp001.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp002.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp003.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp004.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp005.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp006.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp007.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp008.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp009.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp010.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp011.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp012.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp013.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp014.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp015.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp016.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp017.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp018.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp019.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp020.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp021.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp022.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp023.jpg	Edgar Link	pending
vtr-20240331_def.xml	Edgar Link	unprocessable
vtr-20240331_lab.xml	Edgar Link	unprocessable
vtr-20240331_pre.xml	Edgar Link	unprocessable
vtr-20240331_htm.xml	Edgar Link	completed
vtr-ex41_033124tenthsupp024.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp025.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp026.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp027.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp028.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp029.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp030.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp031.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp032.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp033.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp034.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp035.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp036.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp037.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp038.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp039.jpg	Edgar Link	pending
vtr-ex41_033124tenthsupp040.jpg	Edgar Link	pending
vtr-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VTR
Ventas, Inc. Stock $vtr

2024 Q2 Form 10-Q Financial Statement

#000074026024000139 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR Ventas, Inc. Stock $vtr

2024 Q2 Form 10-Q Financial Statement

#000074026024000139 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR
Ventas, Inc. Stock $vtr